Mind Medicine (MindMed) Inc. Share Price Deutsche Boerse AG
Equities
MMQ
CA60255C8850
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.865 EUR | +0.13% | -3.32% | +132.42% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 601M 562M 48.09B |
---|---|---|---|---|---|
Net income 2024 * | -94M -87.91M -7.52B | Net income 2025 * | -106M -99.14M -8.49B | EV / Sales 2024 * | - |
Net cash position 2024 * | 184M 172M 14.75B | Net cash position 2025 * | 99.5M 93.06M 7.97B | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-5.37
x | P/E ratio 2025 * |
-5.81
x | Employees | 57 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.59% |
Latest transcript on Mind Medicine (MindMed) Inc.
1 day | +0.13% | ||
1 week | -3.32% | ||
Current month | -8.12% | ||
1 month | -12.61% | ||
3 months | +136.75% | ||
6 months | +230.74% | ||
Current year | +132.42% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Barrow
CEO | Chief Executive Officer | - | 13/01/21 |
Schond Greenway
DFI | Director of Finance/CFO | 52 | 22/05/22 |
Miri Wernli
PSD | President | 71 | 27/02/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andreas Krebs
BRD | Director/Board Member | 66 | 28/09/21 |
Suzanne Bruhn
BRD | Director/Board Member | 60 | 10/08/22 |
David Gryska
BRD | Director/Board Member | 68 | 20/06/23 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 7.865 | +0.13% | 0 |
25/04/24 | 7.855 | -3.02% | 253 |
24/04/24 | 8.1 | +0.37% | 337 |
23/04/24 | 8.07 | -0.55% | 0 |
22/04/24 | 8.115 | -0.25% | 150 |
Delayed Quote Deutsche Boerse AG, April 26, 2024 at 07:13 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- MNMD Stock
- MMQ Stock